214 related articles for article (PubMed ID: 34610431)
21. Expression of Bak and Bak/Mcl-1 ratio can predict photodynamic therapy outcome for oral verrucous hyperplasia and leukoplakia.
Yu CH; Chen HM; Lin HP; Chiang CP
J Oral Pathol Med; 2013 Mar; 42(3):257-62. PubMed ID: 22974427
[TBL] [Abstract][Full Text] [Related]
22. Ablative fractional laser-assisted photodynamic therapy vs. ablative fractional laser for oral leukoplakia treatment: A randomized, controlled pilot study.
Yao Y; Shi L; Wang Y; Shen X; Ye S; Tang G; Wu L
Photodiagnosis Photodyn Ther; 2021 Dec; 36():102523. PubMed ID: 34487871
[TBL] [Abstract][Full Text] [Related]
23. Application of fractal dimension analysis and photodynamic diagnosis in the case of differentiation between lichen planus and leukoplakia: A preliminary study.
Jurczyszyn K; Kazubowska K; Kubasiewicz-Ross P; Ziółkowski P; Dominiak M
Adv Clin Exp Med; 2018 Dec; 27(12):1729-1736. PubMed ID: 30085425
[TBL] [Abstract][Full Text] [Related]
24. Plum-blossom needle assisted photodynamic therapy for the treatment of oral potentially malignant disorder in the elderly.
Wang X; Han Y; Jin J; Cheng Z; Wang Q; Guo X; Li W; Liu H
Photodiagnosis Photodyn Ther; 2019 Mar; 25():296-299. PubMed ID: 30633997
[TBL] [Abstract][Full Text] [Related]
25. Comparison of cryotherapy and photodynamic therapy in treatment of oral leukoplakia.
Kawczyk-Krupka A; Waśkowska J; Raczkowska-Siostrzonek A; Kościarz-Grzesiok A; Kwiatek S; Straszak D; Latos W; Koszowski R; Sieroń A
Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):148-55. PubMed ID: 22594985
[TBL] [Abstract][Full Text] [Related]
26. A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.
Wong SJ; Campbell B; Massey B; Lynch DP; Cohen EEW; Blair E; Selle R; Shklovskaya J; Jovanovic BD; Skripkauskas S; Dew A; Kulesza P; Parimi V; Bergan RC; Szabo E
Oral Oncol; 2013 Sep; 49(9):970-976. PubMed ID: 23845699
[TBL] [Abstract][Full Text] [Related]
27. Proliferative verrucous leukoplakia: a report of ten cases.
Zakrzewska JM; Lopes V; Speight P; Hopper C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Oct; 82(4):396-401. PubMed ID: 8899776
[TBL] [Abstract][Full Text] [Related]
28. [The use of photodynamic therapy in patients with severe forms of leukoplakia].
Rabinovich OF; Rabinovich IM; Umarova KV; Shindich OI; Kozhedub AA
Stomatologiia (Mosk); 2022; 101(5):11-16. PubMed ID: 36268913
[TBL] [Abstract][Full Text] [Related]
29. Topical photodynamic therapy is the first-line treatment of choice for oral erythroleukoplakia and oral verrucous hyperplasia.
Chen HM; Cheng SJ; Chiang CP
J Formos Med Assoc; 2015 Jul; 114(7):567-8. PubMed ID: 25937480
[No Abstract] [Full Text] [Related]
30. Long-term outcomes of aminolevulinic acid photodynamic therapy for treatment of recalcitrant laryngeal premalignant lesions.
Santeerapharp A; Song SA; Woo P; Franco RA
Clin Otolaryngol; 2022 Jan; 47(1):153-159. PubMed ID: 34662496
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of oral verrucous hyperplasia with photodynamic therapy combined with cryotherapy--report of 3 cases.
Chang YC; Yu CH
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):127-9. PubMed ID: 24561304
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of an extensive verrucous carcinoma with topical 5-aminolevulinic acid-mediated photodynamic therapy.
Chen HM; Chen CT; Yang H; Lee MI; Kuo MY; Kuo YS; Wang YP; Tsai T; Chiang CP
J Oral Pathol Med; 2005 Apr; 34(4):253-6. PubMed ID: 15752262
[TBL] [Abstract][Full Text] [Related]
33. Malignant transformation of oral proliferative verrucous leukoplakia: a series of 48 patients with suggestions for management.
Favia G; Capodiferro S; Limongelli L; Tempesta A; Maiorano E
Int J Oral Maxillofac Surg; 2021 Jan; 50(1):14-20. PubMed ID: 32586723
[TBL] [Abstract][Full Text] [Related]
34. Laser management of oral leukoplakias: a follow-up study of 70 patients.
Schoelch ML; Sekandari N; Regezi JA; Silverman S
Laryngoscope; 1999 Jun; 109(6):949-53. PubMed ID: 10369289
[TBL] [Abstract][Full Text] [Related]
35. Treatment of oral leukoplakia with photodynamic therapy: A pilot study.
Selvam NP; Sadaksharam J; Singaravelu G; Ramu R
J Cancer Res Ther; 2015; 11(2):464-7. PubMed ID: 26148619
[TBL] [Abstract][Full Text] [Related]
36. Vascular alterations after photodynamic therapy mediated by 5-aminolevulinic acid in oral leukoplakia.
Rosin FC; Barcessat AR; Borges GG; Ferreira LG; Corrêa L
Lasers Med Sci; 2017 Feb; 32(2):379-387. PubMed ID: 28004205
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of photodynamic therapy of oral potentially malignant disorder.
Jing Y; Shu R; Wu T; Liu D; Luo X; Sun J; Chen F
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104026. PubMed ID: 38403144
[TBL] [Abstract][Full Text] [Related]
38. Laser-mediated photodynamic therapy of actinic cheilitis.
Alexiades-Armenakas MR; Geronemus RG
J Drugs Dermatol; 2004; 3(5):548-51. PubMed ID: 15552607
[TBL] [Abstract][Full Text] [Related]
39. Lichenoid areas may arise in early stages of proliferative verrucous leukoplakia: A long-term study of 34 patients.
Barba-Montero C; Lorenzo-Pouso AI; Gándara-Vila P; Blanco-Carrión A; Marichalar-Mendía X; García-García A; Pérez-Sayáns M
J Oral Pathol Med; 2022 Jul; 51(6):573-581. PubMed ID: 35596256
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy using topical toluidine blue for the treatment of oral leukoplakia: A prospective case series.
Di Stasio D; Romano A; Russo D; Fiori F; Laino L; Caponio VCA; Troiano G; Muzio LL; Serpico R; Lucchese A
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101888. PubMed ID: 32593778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
